Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease

Statistics in Medicine

Volumn 15, Issue 1, 1996, Pages 75-92

  Mcneil, Alexander J ^a   Gore, Sheila M ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ZIDOVUDINE;

ARTICLE; BAYES THEOREM; CELL COUNT; CELL LOSS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH CURVE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PREDICTION; PROBABILITY; SEROCONVERSION; STATISTICAL ANALYSIS; SYSTEM ANALYSIS;

ANTIVIRAL AGENTS; BAYES THEOREM; CD4 LYMPHOCYTE COUNT; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNOCOMPETENCE; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; MONTE CARLO METHOD; REGRESSION ANALYSIS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0030065374     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960115)15:1<75::AID-SIM142>3.0.CO;2-8     Document Type: Article

References (35)

1. Lang, W., Perkins, H., Anderson, R. E., Royce, R., Jewell, N. and Winkelstein, W. 'Patterns of T-lymphocyte changes with human immunodeficiency virus infection from seroconversion to the development of AIDS' Journal of Acquired Immune Deficiency Syndromes, 2, 63-69 (1989).
2. Phillips, A. N., Lee, C. A., Elford, J., Janossy, G., Timms, A., Bofill, M. and Kernoff, P. B. A. 'Serial CD4 lymphocyte counts and development of AIDS', Lancet, 337, 389-392 (1991).
3. Taylor, J. M. G., Fahey, J. L., Detels, R. and Giorgi, J. V. 'CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: which to choose and how to use', Journal of Acquired Immune Deficiency Syndromes, 2, 114-124 (1989).
4. Fahey, J. L., Taylor, J. M. G., Detels, R., Hofmann, B., Melmed, R., Nishanian, P. and Giorgi, J. V. 'The prognostic value of cellular and serologic markers in infection with immunodeficiency virus type 1', New England Journal of Medicine, 322, 166-172 (1990).
5. Leoung, G. S., Feigal, D. W., Montgomery, A. B., Corkery, K., Wardlaw, L. 'Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco Community Prophylaxis Trial', New England Journal of Medicine, 323, 769-775 (1990).
6. Longini, I. M., Clark, W. S., Gardner, L. I. and Brundage, J. F. 'The dynamics of CD4 + T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach', Journal of Acquired Immune Deficiency Syndromes, 4, 1141-1147 (1991).
7. Le, N. D., Schechter, M. T., Le, T. N., Craib, K. J. P. and Montaner, J. S. G. 'Use of the Markov model to estimate the waiting times for the proposed WHO clinical staging of HIV infection in a cohort of homosexual men. Abstract WC40', In 7th International Conference on AIDS, Florence, 1991.
8. Phillips, A. N., Lee, C. A., Elford, J., Janossy, G., Bofill, M., Timms, A. and Kernoff, P. B. A. 'Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort', AIDS, 3, 737-741 (1989).
9. DeGruttola, V., Lange, N. and Dafni, U. 'Modelling the progression of HIV infection'. Journal of the American Statistical Association, 86, 569-577 (1991).
10. Lange, N., Carlin, B. P. and Gelfand, A. E. 'Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers (with comments and rejoinder to comments)', Journal of the American Statistical Association, 87, 615-626 (1992).
11. Kiuchi, A. S., Hartigan, J. A., Holford, T. R. and Stevens, C. E. 'Change points in the series of T4 counts', Biometrics, 1994. To appear.
12. Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D. et al. 'The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex', New England Journal of Medicine, 317, 185-191 (1987).
13. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A. et al. 'Zidovudine in asymptomatic human immunodeficiency virus infection', New England Journal of Medicine, 322, 941-949 (1990).
14. Fischl, M. A., Richmann, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy D., Dolin, R., Powderly, W. G. et al. 'The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind placebocontrolled trial', Annals of Internal Medicine, 112, 727-737 (1990).
15. Concorde Coordinating Committee. 'Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection', Lancet, 343, 871-881 (1994).
16. Gilks, W. R., Clayton, D. G., Spiegelhalter, D. J., Best, N. G., McNeil, A. J., Sharples, L. D. and Kirby, A. J. 'Modelling complexity: applications of Gibbs sampling in medicine', Journal of the Royal Statistical Society, Series B, 55, 39-52 (1993).
17. Brettle, R. P., Gore, S. M., and McNeil, A. Out patient medical care of injection drug use related HIV', International Journal of STD and AIDS, 3, 96-100 (1992).
18. Graham, N. M. H., Zeger, S. L., Park, L. P., Phair, J. P., Detels, R., Vermund, S. H., Ho, M. and Saah, A. J. 'Effect of zidovudine and pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS', Lancet, 338, 265-269 (1991).
19. Fearn, T., 'A Bayesian approach to growth curves', Biometrika, 62, 89-100 (1975).
20. Laird, N. M. and Ware, J. H. 'Random-effects models for longitudinal data', Biometrics, 38, 963-974 (1982).
21. Gelfand, A. E., Hills, S. E., Racine-Poon, A. and Smith, A. F. M. 'Illustration of Bayesian inference in normal data models using Gibbs sampling', Journal of the American Statistical Association, 85, 972-985 (1990).
22. Gelfand, A. E., and Smith A. F. M., 'Sampling based approaches to calculating marginal densities', Journal of the American Statistical Association, 85, 398-409 (1990).
23. Racine-Poon, A., Smith, A. F. M. and Gelfand, A. E. 'Bayesian analysis of population models using the Gibbs sampler', Unpublished?
24. Johnson, N. L. and Kotz, S. Distributions in Statistics: Continuous Multivariate Wiley, 1972.
25. Smith A. F. M. and Roberts, G. O. 'Bayesian computation via the Gibbs sampler and related Markov chain Monte Carlo methods', Journal of the Royal Statistical Society, Series B, 55, 3-23 (1993).
26. Gelman, A. and Rubin, D. B. 'A single series from the Gibbs sampler provides a false sense of security, in: Bernardo J. M., Berger, J. O., Dawid, A. P. and Smith, A. F. M. (eds), Bayesian Statistics 4, Clarendon Press, Oxford, 1992.
27. Geweke, J. 'Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments', in: Bernardo J., Berger, J., Dawid, A. P. and Smith, A. F. M. (eds), Bayesian Statistics 4, Clarendon Press, Oxford, 1992.
28. Raftery, A. E. and Lewis, S. M. 'How many iterations in the Gibbs sampler?, in: Bernardo J. M., Berger, J. O., Dawid, A. P. and Smith, A. F. M. (eds), Bayesian Statistics 4, Clarendon Press, Oxford, 1992.
29. Gelfand, A. E., Dey, D. K. and Chang, H. 'Model determination using predictive distributions with implementation via sampling-based methods', in: Bernardo J., Berger, J., Dawid, A. P. and Smith, A. F. M. (eds), Bayesian Statistics 4, Clarendon Press, Oxford, 1992.
30. Rubin, D. B. 'Bayesianly justifiable and relevant frequency calculations for the applied statistician', The Annals of Statistics, 12, 1151-1172 (1984).
31. Clayton, D. G. 'A Monte Carlo method for Bayesian inference in frailty models', Biometrics, 47, 467-485 (1991).
32. Gelfand, A. E. and Dey, D. K. 'Bayesian model choice: Asymptotics and exact calculations', Journal of the Royal Statistical Society, Series B, 56, 501-514 (994).
33. Goldstein, H. 'Multilevel mixed linear model analysis using iterative least squares', Biometrika, 73, 43-56 (1986).
34. MAP Workshop. 'Marker paths', Statistics in Medicine, 12, 2099-2126 (1993).
35. Steel, C. M., Ludlam, C. A., Beatson, D., Peutherer, J. F., Cuthbert, R. J. G., Simmonds, P., Morrison, H. and Jones, M. 'HLA haplotype A1, B8, DR3 as a risk factor for HIV-related disease', Lancet, 1, 1185-1188 (1988).